Metabolic Consequences of CPT-1 Deficiency

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions
Carnitine Palmitoyl Transferase Type 1A (CPT1A) Deficiency
Interventions
OTHER

Medically supervised fasting

Metabolic fasting studies will be conducted over an 18-hour period or until blood glucose is \< 40 mg/dl. If the YSI reading is 40 mg/dl or less, at any time during the study, then a blood sample will be collected, and the fast terminated by giving D25W IV and then feeding orally.

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Alaska Department of Health and Social Services

UNKNOWN

lead

Oregon Health and Science University

OTHER

NCT00653666 - Metabolic Consequences of CPT-1 Deficiency | Biotech Hunter | Biotech Hunter